Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and Neck

NCT07644585 is registered in ClinicalTrials.gov with IBA Proton Therapy, Inc. as lead sponsor.

NCT NCT07644585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07644585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and Neck
Lead sponsor
IBA Proton Therapy, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
September 14, 2026
Completion date
December 31, 2032
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer